Figure 2

Subgroup analyses for the overall survival (OS) and disease-free survival (DFS) of HCC patients with high and low Cbx4 expression in low grade (a) or high grade (b) and in tumor size of ≤5 or >5 cm group patients (c and d)

Subgroup analyses for the overall survival (OS) and disease-free survival (DFS) of HCC patients with high and low Cbx4 expression in low grade (a) or high grade (b) and in tumor size of ≤5 or >5 cm group patients (c and d)